Dernières nouvelles pour Global X Cybersecurity ETF (NASDAQ:BUG)

Technology

Other

The Fund invests at least 80 percent of its total assets in the securities of the Indxx Cybersecurity Index (Underlying Index) and in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) based on the securities in the Underlying Index. The Fund will also invest, under normal circumstances, at least 80 percent of its net assets, plus borrowings for investment purposes (if any), in Cybersecurity Companies (as defined below), and in ADRs and GDRs based on such securities. The Fund's 80 percent investment policies are non-fundamental and require 60 days prior written notice to shareholders before they can be changed. The Fund may lend securities representing up to one-third of the value of the Funds total assets (including the value of the collateral received).

Check Point Software Technologies Ltd.

Palo Alto Networks Inc.

Zscaler Inc

Gen Digital Inc

Okta Inc.

Varonis Systems Inc

Fortinet Inc.

SentinelOne Inc.

Crowdstrike Holdings Inc. Class A

A10 Networks Inc

Ahnlab Inc

Digital Arts Inc

Global X Cybersecurity ETF

BUMRUNGRAD HOSPITAL NVDR by Bumrungrad Hospital Public Co., Ltd.

Bumrungrad Hospital PCL

Bluglass Ltd

PRIMO NUTRACEUTICALS by Primo Nutraceuticals Inc.

<p>Truist Securities  analyst Tobey Sommer   maintains ManpowerGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAN#NYSE">MAN</a>) with a Hold and lowers the price target from $55 to $48.</p>


News

Price Target

Analyst Ratings

Truist Securities Maintains Hold on ManpowerGroup, Lowers Price Target to $48

<p><em>XPANCEO founders on building the first interface designed for the body, not the screen — and why human–tech integration is the next leap forward.</em></p>
<p>When it comes to the future of interfaces, we're used to bold claims: AR glasses will replace phones. Brain-computer interfaces will merge us with machines. But beneath the noise, the real breakthroughs start in a lab, where biology meets engineering, and technology is made compact enough to work inside the human body itself. That's where <a href="https://xpanceo.com/">XPANCEO</a> is operating — developing something deceptively small: a smart contact lens.</p>
<p>We could just stop at the technical side of things — describing it as a compact, next-gen device with integrated microdisplays, biosensors, and wireless power delivery. But that wouldn't capture what makes it significant — because what XPANCEO is building is a new kind of interface, one designed not for screens, but for the human body itself.&nbsp;</p>
<p>I spoke with founders <a href="https://www.linkedin.com/in/romanaxelrod/">Roman Axelrod</a> and <a href="https://www.linkedin.com/in/valentyn-volkov/">Dr. Valentyn Volkov</a> to better understand the science, the challenges, and what it means to build an interface that's so intimate it's worn on the surface of the eye.</p>
<h2 class="wp-block-heading">Why Downscaling Doesn't Work — And What Does</h2>
<p>Rather than downsizing existing smartphone components, XPANCEO had to rethink materials entirely, focusing on implementing next-generation technologies specifically designed for ultra-small-scale applications.&nbsp;</p>
<p><em>"The conventional approach — shrinking phone components into something eye-sized — doesn't work," </em>Dr. Valentyn Volkov explained. <em>"It's not just a size problem; it's about weight, power efficiency, and heat dissipation. So we had to rethink everything."</em></p>
<p>XPANCEO approached the contact lens from the ground up — not as a wearable gadget, but as a biologically integrated system. The team needed flexibility, conductivity, and high performance in an exceptionally small format. So they turned to novel ultra-thin 2D materials — just atoms thick&nbsp; — small and light enough to fit into a contact lens, yet capable of maintaining high performance.&nbsp;</p>
<p>That progress, however, relied not just on materials — but primarily on expertise. Co-founder Dr. Valentyn Volkov, with a background in nanophotonics, nano-optics, and applied research across leading international institutions, helped bring together materials science, AI, and next-gen optics to build systems that work reliably at a microscopic scale.</p>
<p><em>"His know-how was vital to helping us design and fine-tune systems that work reliably at such a small scale," </em>Axelrod said, noting that this level of precision is absolutely essential to building technology for the surface of the eye.</p>
<h2 class="wp-block-heading">A Smarter Way to Know When to See a Doctor</h2>
<p>By detecting biomarkers like glucose and hormone levels in the user&#8217;s tear fluid, the contact lens can be used for non-stop, non-invasive health monitoring. Spotting problems early becomes a reality thanks to these biosensing capabilities, which also help create personalized prevention plans.</p>
<p>Naturally, I wanted to know how this stacks up against the gold standard — so I asked whether tear-based readings could ever rival the accuracy of blood diagnostics.</p>
<p>Dr. Volkov acknowledged this challenge but was careful to draw the line between potential and clinical equivalence:</p>
<p><em>"It's true — biomarker levels in tear fluid are way lower than in blood, sometimes by orders of magnitude. But we've developed highly sensitive detection systems that can pick up and amplify those weak signals — using advanced nanomaterials, smart signal processing, and built-in electronics right inside the contact lens."</em></p>
<p><em>"That said, we want to be clear about where things stand. We're already seeing good results detecting some clinically relevant biomarkers, but we're not quite at blood-test-level accuracy at the moment. So for now, we're not ready to say it's on par with gold-standard blood diagnostics just yet."</em></p>
<p>He added that the goal is not to displace diagnostics at all:</p>
<p>&nbsp;<em>"We're building a complementary layer — a longitudinal view that may one day signal when a deeper test is warranted."&nbsp;</em></p>
<p>Unlike standard lab tests, which only capture isolated snapshots of a person's health, the contacts are designed to provide a real-time stream of physiological data. This ongoing perspective can help reveal early warning signs or subtle deviations in biomarker levels — the kind that might go unnoticed in traditional diagnostics — and prompt the user to consult a physician before symptoms even appear.&nbsp;</p>
<p>The team is also exploring integration with drug delivery systems through the contact lens, which is especially relevant for chronic conditions like glaucoma or dry eye syndrome. According to Dr. Volkov, this could help improve medication adherence and fine-tuning of dosages by linking drug release to real-time biomarker levels.</p>
<p><em>"We're not trying to replace clinical diagnostics — we're creating a system that can detect when something's off," </em>he explained. <em>"Smart contact lenses might not be ready for clinical use just yet, but they're already shaping up to be a powerful preventive health companion."</em></p>
<h2 class="wp-block-heading">No Screens, No Swipes — So How Do You Interact with It?</h2>
<p>Interaction was never going to follow the smartphone model. You can't pinch or tap your cornea. Instead, XPANCEO is exploring several input methods — some familiar, others deeply biological.</p>
<p>You might not think about it often, but your tongue is one of the most electrically active and sensitive muscles in the body. It's packed with nerves, and every movement it makes generates tiny bioelectrical signals — a fact that forms the basis of what scientists call glossokinetic control.&nbsp;</p>
<p>Recognizing this, Dr. Volkov and his team at XPANCEO are exploring how these signals can be used to interact with digital content:</p>
<p><em>"It's a discreet and precise method, well-suited to everyday use, without the need for touchscreens or gestures."</em></p>
<p>The eye-tracking system is equally hands-free, allowing users to select and navigate digital elements just by looking.</p>
<p><em>"The contact lens has a patent-pending eye-tracking system built in," </em>he said. <em>"It lets people interact with content just by shifting their gaze — it's fast, natural, and invisible to others."</em></p>
<p>Facial micro-expressions and voice input offer additional layers of control, making the system adaptable to different settings and needs. While voice isn't ideal in crowded or public environments, it can still serve as a reliable fallback — especially when paired with AI that can interpret user intent.</p>
<p><em>"We're working toward a multimodal interaction system that adapts to the user — not the other way around,"</em> Dr. Volkov added. <em>"It's about making the tech adjust to your context, not forcing you to adapt to the tech."</em></p>
<h2 class="wp-block-heading">The Smart Contact Lens Shift: Screens, Safety, and Social Norms</h2>
<p>Smart contacts, if they scale, won't replace screens — they'll just rearrange them.</p>
<p><em>"Screens will still exist," </em>Axelrod said.<em> "But they'll become less central. Just like smartphones didn't eliminate PCs, smart contacts won't eliminate other interfaces — they'll just push them to evolve into forms that feel more natural."</em></p>
<p>What makes this shift so significant isn't just the technology itself — it's the intimacy of the interface. This isn't a wearable. It's something worn directly on the eye. It becomes, in a sense, part of the body. And that raises questions far beyond user experience — from surveillance and privacy to social norms and the psychological effects of persistent AR.</p>
<p><em>"People didn't reject the technology — they rejected how alien it made the wearer look," </em>Axelrod said, referring to early reactions to headsets like Vision Pro.<em> "That's not a problem for something as discreet as a contact lens."</em></p>
<p>But discreet doesn't mean invisible in terms of impact. As with any tech that disappears into the body, new boundaries will need to emerge — and the XPANCEO team is building with that in mind.</p>
<p>Because the contact lens is worn on the eye, XPANCEO is treating it not as a consumer gadget, but as a medical device. Roman Axelrod said the company is preparing for pre-clinical trials and expects full-lens trials to begin by the end of 2026:</p>
<p><em>"There's no shortcut around biocompatibility testing and clinical validation,"</em> he said. <em>"These processes are detailed and time-consuming, yet absolutely essential."</em></p>
<p>The regulatory landscape for this kind of technology doesn't fully exist yet, which puts XPANCEO in the position of helping define what compliance looks like for ocular XR systems.</p>
<p>And safety isn't only about biology. With sensors potentially collecting biometric or environmental data, Axelrod noted that safeguards are being built directly into the system — including AI-powered restrictions that limit use in sensitive or high-risk environments.</p>
<p>"<em>We've heard it all — from students dreaming of passing exams without studying to people picturing themselves watching YouTube while driving,"</em> he said. <em>"As funny as it sounds, it's exactly why smart systems need smart limits."</em></p>
<p><em>"Of course, no technology can eliminate misuse entirely — people still use phones where they shouldn't," </em>he added. <em>"But we're building safeguards into the contact lens itself to encourage responsible use and ensure it complies with local laws and regulations."</em></p>
<h2 class="wp-block-heading">Toward the Next Evolution of Human</h2>
<p>To hear Axelrod describe it, XPANCEO's project isn't just about engineering a contact lens. It's about building a proof of concept for a broader shift — from external tools to internal augmentation.</p>
<p><em>"I believe we're heading toward a transhumanist future — not in a speculative sense, but in a technical one," </em>he said.<em> "The capabilities we'll need to survive in space, treat neurodegenerative diseases, or even expand our sensory range — those won't come from devices we hold. They'll come from ones we integrate."</em></p>
<p>That may sound like ideology. But when you're embedding systems directly onto the eye — and they work — it becomes harder to dismiss the possibility.&nbsp;</p>
<p>And Axelrod doesn't see XPANCEO as the only player in this shift. As more companies blur the line between biology and technology, he sees a future where human potential itself begins to evolve:</p>
<p><em>"Over the next decade, I think we'll start to see what it really means when biology and tech become indistinguishable. This isn't just about convenience. It's about expanding what humans are capable of — to become more adaptive, more resilient, and even interplanetary."</em></p>
<p>Whether or not that future unfolds exactly as imagined, the trajectory feels unmistakable. The contact lens, in this sense, is a first step — a signal that the most powerful interfaces may not be the ones that dazzle, but the ones that disappear into the body, bringing us closer to a world where human limitations are no longer the end of the story.</p>


Health Care

Opinion

Tech

Interview

The Next Human Evolution Starts At The Surface Of The Eye: A Conversation With XPANCEO's Founders On Human-Integrated Interfaces

<p><strong>Old National</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NASDAQ">ONB</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Old National will report an <strong>earnings per share</strong> (EPS) of $0.43. </p>
<p>Anticipation surrounds Old National's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous earnings release, the company beat EPS by $0.03, leading to a 0.93% drop in the share price the following trading session.</p>
<p>Here's a look at Old National's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.46</td>
<td>0.46</td>
<td>0.44</td>
<td>0.43</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.49</td>
<td>0.46</td>
<td>0.46</td>
<td>0.45</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>0.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251334_0.png" alt="eps graph" /></p>
<h3>Tracking Old National's Stock Performance</h3>
<p>Shares of Old National were trading at $19.59 as of April 18. Over the last 52-week period, shares are up 16.27%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/ONB/earnings"><strong>To track all earnings releases for Old National visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

Insights into Old National's Upcoming Earnings

<p>West Fraser Timber (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFG#NYSE">WFG</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-22. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that West Fraser Timber will report an <strong>earnings per share</strong> (EPS) of $0.56.</p>
<p>The announcement from West Fraser Timber is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Historical Earnings Performance</h3>
<p>Last quarter the company beat EPS by $0.04, which was followed by a 3.83% drop in the share price the next day.</p>
<p>Here's a look at West Fraser Timber's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.06</td>
<td>-0.50</td>
<td>1.32</td>
<td>0.30</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.10</td>
<td>-1.03</td>
<td>1.20</td>
<td>0.42</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-4.0%</td>
<td>1.0%</td>
<td>7.000000000000001%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251325_0.png" alt="eps graph" /></p>
<h3>Performance of West Fraser Timber Shares</h3>
<p>Shares of West Fraser Timber were trading at $73.29 as of April 18. Over the last 52-week period, shares are down 8.02%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/WFG/earnings"><strong>To track all earnings releases for West Fraser Timber visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What to Expect from West Fraser Timber's Earnings

<p><strong>Range Resources</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRC#NYSE">RRC</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Range Resources will report an <strong>earnings per share</strong> (EPS) of $0.89. </p>
<p>Anticipation surrounds Range Resources's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company's EPS beat by $0.08 in the last quarter, leading to a 2.8% increase in the share price on the following day.</p>
<p>Here's a look at Range Resources's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.60</td>
<td>0.38</td>
<td>0.42</td>
<td>0.57</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.68</td>
<td>0.48</td>
<td>0.46</td>
<td>0.69</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>3.0%</td>
<td>4.0%</td>
<td>-4.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251314_0.png" alt="eps graph" /></p>
<h3>Tracking Range Resources's Stock Performance</h3>
<p>Shares of Range Resources were trading at $34.18 as of April 18. Over the last 52-week period, shares are down 9.49%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Observations about Range Resources</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Range Resources.</p>
<p>Range Resources has received a total of 15 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $41.27, the consensus suggests a potential 20.74% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Permian Resources, Ovintiv and APA, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Permian Resources, with an average 1-year price target of $18.5, suggesting a potential 45.87% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Ovintiv, with an average 1-year price target of $51.5, suggesting a potential 50.67% upside.</li>
<li>Analysts currently favor an Neutral trajectory for APA, with an average 1-year price target of $25.55, suggesting a potential 25.25% downside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
<p>In the peer analysis summary, key metrics for Permian Resources, Ovintiv and APA are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Range Resources</td>
<td>Neutral</td>
<td>4.50%</td>
<td>$207.72M</td>
<td>2.42%</td>
</tr>
<tr>
<td>Permian Resources</td>
<td>Outperform</td>
<td>15.44%</td>
<td>$575.46M</td>
<td>2.45%</td>
</tr>
<tr>
<td>Ovintiv</td>
<td>Outperform</td>
<td>-30.89%</td>
<td>$1.19B</td>
<td>-0.57%</td>
</tr>
<tr>
<td>APA</td>
<td>Neutral</td>
<td>25.15%</td>
<td>$1.10B</td>
<td>6.81%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Range Resources is positioned in the middle among its peers for revenue growth, with a growth rate of 4.50%. It ranks at the bottom for gross profit at $207.72M. In terms of return on equity, Range Resources is also at the bottom with a rate of 2.42%.</p>
<h3>Discovering Range Resources: A Closer Look</h3>
<p>Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.18 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.</p>
<h3>Range Resources: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Range Resources's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>4.5%</strong> as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.</p>
<p><strong>Net Margin:</strong> Range Resources's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of <strong>14.16%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Range Resources's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>2.42%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>1.29%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Range Resources's debt-to-equity ratio is below the industry average at <strong>0.46</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/RRC/earnings"><strong>To track all earnings releases for Range Resources visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Range Resources's Earnings: A Preview

<p><strong>Kevin O&#8217;Leary</strong> is standing firmly behind <strong>Donald Trump&#8217;s</strong> trade policies, especially when it comes to China. During a recent appearance on <a href="https://www.youtube.com/watch?v=ztWvIPUxT0s">MSNBC</a>, the &#8220;Shark Tank&#8221; investor and chair of <strong>O&#8217;Leary Ventures</strong> dismissed the idea that tariffs are harming American companies. Instead, he said <a href="https://www.benzinga.com/markets/equities/25/04/44711364/kevin-oleary-calls-for-hefty-400-us-tariffs-on-china-they-dont-play-by-the-rules">they&#8217;re overdue</a>.</p>
<h2 class="wp-block-heading">Tariffs Are Just One Part of the Strategy</h2>
<p>O&#8217;Leary argued that Trump's approach to negotiating tariffs with more than 60 countries is something no other administration has tried. &#8220;Usually, you do a NAFTA-kind of deal,&#8221; he said. &#8220;This is just different.&#8221;</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><strong>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2"><strong>Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</strong></a></strong></li>
<li><strong>Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv"><strong>Own a piece of the $100 billion Metaverse for just $500</strong></a>.</strong></li>
</ul>
<p>He believes most of those situations will work themselves out, even naming countries like Vietnam and Germany as examples of those already engaging with the U.S. on trade talks. For him, those are manageable.</p>
<h2 class="wp-block-heading">The Bigger Problem Is China</h2>
<p>The real threat, O&#8217;Leary said, is China. &#8220;China is cheating, stealing, ripping off IP, wiping out American companies—many of them mine,&#8221; he said. He claimed that since joining the World Trade Organization in 2000, China has ignored intellectual property laws, costing the U.S. dearly.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">I wanna solve this because I&#39;m a guy that actually does business there and I&#39;m telling you, they wipe out thousands, if not millions, of American companies that get to five million in sales. I&#39;m just one voice, but I think that narrative&#39;s starting to pick up a little momentum… <a href="https://t.co/IUGFh9vuZo">pic.twitter.com/IUGFh9vuZo</a></p>
<p>&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1912274762874704090?ref_src=twsrc%5Etfw">April 15, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>&#8220;They don&#8217;t even care about IP laws. It's beyond ridiculous,&#8221; he said. O&#8217;Leary estimated that millions of U.S. businesses have been harmed, especially small ones. &#8220;I'm just speaking on behalf of every small entrepreneur in America, and I think I have my army behind me,&#8221; he said.</p>
<p><strong>Trending: With high-demand properties in the Midwest, Bam Capital has delivered 2.46x equity multiples in just over 3 years. No losses. No missed payments. <a href="https://www.benzinga.com/money/investing-in-the-midwest-why-multifamily-real-estate-is-a-winning-strategy"><strong>Learn more about becoming an investor today</strong></a>.&nbsp;</strong></p>
<p>Adding to the broader conversation around intellectual property, <strong>Elon Musk</strong>, CEO of Tesla, and <strong>Jack Dorsey</strong>, co-founder of Twitter and Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>), have stirred debate recently by <a href="https://www.benzinga.com/markets/25/04/44783776/elon-musk-jack-dorsey-call-for-abolition-of-all-intellectual-property-laws-arguing-there-are-much-greater-models-to-pay-creators">suggesting the complete eradication of IP laws</a>. The idea has sparked controversy across the tech industry, with some seeing it as innovative and others viewing it as dangerous.</p>
<h2 class="wp-block-heading">A Game of Leverage</h2>
<p>While critics like economist <strong>Paul Krugman</strong> and investor <a href="https://www.benzinga.com/personal-finance/25/04/44778587/we-are-heading-for-a-self-induced-economic-nuclear-winter-billionaire-investor-bill-ackman-has-turned-on-trump-over-tariffs"><strong>Bill Ackman</strong> have called the trade war</a> risky or a failure, O&#8217;Leary disagreed. He believes the only way to deal with China is through leverage. &#8220;This is a game of chicken right now,&#8221; he said, adding that higher tariffs may be necessary to bring China to the negotiating table.</p>
<p>O&#8217;Leary said he doesn&#8217;t support politicians, just policy. He emphasized that while many people are focused on hating Trump, they&#8217;re missing the policy argument. &#8220;There are millions of American companies wiped out by what China does,&#8221; he said. &#8220;I don't know why you're okay with it. You shouldn't be.&#8221;</p>
<p>He continued, &#8220;62% of jobs in America are created by companies with 5 to 500 employees. I am their advocate and we&#8217;re pissed.&#8221;</p>
<p><strong><em>See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel"><strong><em>invest pre-IPO from $0.60 per share now</em></strong></a></em></strong><strong><em>.</em></strong></p>
<h2 class="wp-block-heading">Hope for Progress</h2>
<p>Despite the friction, O&#8217;Leary said he still wants to do business with China and sees opportunity there. But he said that the current situation can't continue. &#8220;We want to form some kind of a union that's not so antagonistic. But you can't cheat, you can&#8217;t steal,&#8221; he said.&nbsp;</p>
<p>He&#8217;s optimistic that the trade policy will start to show results soon. &#8220;Give it a few weeks,&#8221; he said. &#8220;I think we're going to get something worked out here. <a href="https://www.benzinga.com/news/global/25/04/44777274/kevin-oleary-says-xi-jinping-is-playing-with-fire-if-this-gamble-doesnt-pay-off">Xi is also in a bad place</a>.&#8221;</p>
<p>In the meantime, he says he&#8217;s speaking for the small businesses that can&#8217;t afford to keep losing to a system that, in his view, has been rigged for too long.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks"><strong>One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</strong></a></strong></li>
<li><strong>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2"><strong>with $1,000 you can invest at just $0.26/share!</strong></a></strong></li>
</ul>
<p><strong><em>Image: Shutterstock</em></strong></p>


Kevin O'Leary Says China's Actions Have 'Wiped Out' Millions Of American Companies—'I Don't Know Why Anyone Is Okay With It'

<p>Agree Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADC#NYSE">ADC</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-22. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Agree Realty to report an <strong>earnings per share</strong> (EPS) of $1.05.</p>
<p>Investors in Agree Realty are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Historical Earnings Performance</h3>
<p>In the previous earnings release, the company beat EPS by $0.01, leading to a 1.65% drop in the share price the following trading session.</p>
<p>Here's a look at Agree Realty's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.03</td>
<td>1.03</td>
<td>1.03</td>
<td>1.01</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.04</td>
<td>1.03</td>
<td>1.04</td>
<td>1.03</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>2.0%</td>
<td>2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251305_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Agree Realty were trading at $79.05 as of April 18. Over the last 52-week period, shares are up 36.71%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Insights Shared by Analysts on Agree Realty</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Agree Realty.</p>
<p>Analysts have provided Agree Realty with 6 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $78.0, suggesting a potential 1.33% downside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Federal Realty Investment, NNN REIT and Brixmor Property Group, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Federal Realty Investment, with an average 1-year price target of $113.22, suggesting a potential 43.23% upside.</li>
<li>Analysts currently favor an Neutral trajectory for NNN REIT, with an average 1-year price target of $44.17, suggesting a potential 44.12% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Brixmor Property Group, with an average 1-year price target of $29.61, suggesting a potential 62.54% downside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
<p>The peer analysis summary outlines pivotal metrics for Federal Realty Investment, NNN REIT and Brixmor Property Group, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Agree Realty</td>
<td>Outperform</td>
<td>11.49%</td>
<td>$140.37M</td>
<td>0.83%</td>
</tr>
<tr>
<td>Federal Realty Investment</td>
<td>Outperform</td>
<td>6.73%</td>
<td>$209.50M</td>
<td>2.09%</td>
</tr>
<tr>
<td>NNN REIT</td>
<td>Neutral</td>
<td>1.04%</td>
<td>$207.34M</td>
<td>2.24%</td>
</tr>
<tr>
<td>Brixmor Property Group</td>
<td>Neutral</td>
<td>3.78%</td>
<td>$242.50M</td>
<td>2.84%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Agree Realty ranks highest in Revenue Growth among its peers. It has the lowest Gross Profit margin. The company's Return on Equity is the lowest among its peers. Overall, Agree Realty is positioned in the middle compared to its peers in terms of consensus rating.</p>
<h3>Delving into Agree Realty's Background</h3>
<p>Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.</p>
<h3>Agree Realty's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Growth:</strong> Agree Realty's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>11.49%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.</p>
<p><strong>Net Margin:</strong> Agree Realty's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>26.92%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Agree Realty's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>0.83%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Agree Realty's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>0.52%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> Agree Realty's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.53</strong>.</p>
<p><a href="https://www.benzinga.com/quote/ADC/earnings"><strong>To track all earnings releases for Agree Realty visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Look at Agree Realty's Upcoming Earnings Report

<p>Stephens &amp; Co.  analyst Matt Olney   reiterates Home BancShares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOMB#NYSE">HOMB</a>) with a Overweight and maintains $33 price target.</p>


Reiteration

HOMB

Stephens & Co. Reiterates Overweight on Home BancShares, Maintains $33 Price Target

<p><strong>Valmont Industries</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Valmont Industries will report an <strong>earnings per share</strong> (EPS) of $4.36. </p>
<p>Investors in Valmont Industries are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company beat EPS by $0.22, which was followed by a 2.58% drop in the share price the next day.</p>
<p>Here's a look at Valmont Industries's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>3.62</td>
<td>4</td>
<td>4.08</td>
<td>3.25</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>3.84</td>
<td>4.11</td>
<td>4.76</td>
<td>4.32</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-3.0%</td>
<td>10.0%</td>
<td>11.0%</td>
<td>18.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251294_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Valmont Industries were trading at $277.83 as of April 18. Over the last 52-week period, shares are up 26.72%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analysts' Take on Valmont Industries</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Valmont Industries.</p>
<p>The consensus rating for Valmont Industries is Buy, based on 4 analyst ratings. With an average one-year price target of $383.75, there's a potential 38.12% upside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Fluor, Dycom Industries and Construction Partners, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Fluor, with an average 1-year price target of $48.62, suggesting a potential 82.5% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Dycom Industries, with an average 1-year price target of $199.83, suggesting a potential 28.07% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Construction Partners, with an average 1-year price target of $98.5, suggesting a potential 64.55% downside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Fluor, Dycom Industries and Construction Partners, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Valmont Industries</td>
<td>Buy</td>
<td>2.14%</td>
<td>$313.02M</td>
<td>5.04%</td>
</tr>
<tr>
<td>Fluor</td>
<td>Buy</td>
<td>11.52%</td>
<td>$208M</td>
<td>60.10%</td>
</tr>
<tr>
<td>Dycom Industries</td>
<td>Outperform</td>
<td>13.87%</td>
<td>$196.58M</td>
<td>2.64%</td>
</tr>
<tr>
<td>Construction Partners</td>
<td>Neutral</td>
<td>41.63%</td>
<td>$76.57M</td>
<td>-0.44%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Valmont Industries ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth and below average for Consensus rating.</p>
<h3>Discovering Valmont Industries: A Closer Look</h3>
<p>Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting and transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.</p>
<h3>Understanding the Numbers: Valmont Industries's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Valmont Industries displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately <strong>2.14%</strong>. This indicates a notable increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Valmont Industries's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>7.49%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Valmont Industries's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>5.04%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Valmont Industries's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>2.27%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> Valmont Industries's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.56</strong>.</p>
<p><a href="https://www.benzinga.com/quote/VMI/earnings"><strong>To track all earnings releases for Valmont Industries visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Outlook For Valmont Industries

<p>JP Morgan  analyst Domingos Falavina   maintains Banco Macro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMA#NYSE">BMA</a>) with a Neutral and raises the price target from $78 to $89.</p>


JP Morgan Maintains Neutral on Banco Macro, Raises Price Target to $89

<p><strong>Synchrony Finl</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Synchrony Finl will report an <strong>earnings per share</strong> (EPS) of $1.67. </p>
<p>The market awaits Synchrony Finl's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings Track Record</h3>
<p>Last quarter the company missed EPS by $0.01, which was followed by a 3.17% increase in the share price the next day.</p>
<p>Here's a look at Synchrony Finl's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.92</td>
<td>1.79</td>
<td>1.35</td>
<td>1.35</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.91</td>
<td>1.94</td>
<td>1.55</td>
<td>1.18</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>3.0%</td>
<td>0.0%</td>
<td>-3.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251281_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Synchrony Finl were trading at $47.87 as of April 18. Over the last 52-week period, shares are up 8.48%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Opinions on Synchrony Finl</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Synchrony Finl.</p>
<p>The consensus rating for Synchrony Finl is Neutral, based on 9 analyst ratings. With an average one-year price target of $67.11, there's a potential 40.19% upside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of FirstCash Hldgs and Enova International, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for FirstCash Hldgs, with an average 1-year price target of $137.0, suggesting a potential 186.19% upside.</li>
<li>Analysts currently favor an Buy trajectory for Enova International, with an average 1-year price target of $134.5, suggesting a potential 180.97% upside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
<p>The peer analysis summary provides a snapshot of key metrics for FirstCash Hldgs and Enova International, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Credit Acceptance</td>
<td>Neutral</td>
<td>14.89%</td>
<td>$351.10M</td>
<td>8.95%</td>
</tr>
<tr>
<td>FirstCash Hldgs</td>
<td>Outperform</td>
<td>3.72%</td>
<td>$433.69M</td>
<td>4.12%</td>
</tr>
<tr>
<td>Enova International</td>
<td>Buy</td>
<td>25.01%</td>
<td>$336.05M</td>
<td>5.36%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Synchrony Financial ranks in the middle among its peers for Consensus rating. It is at the top for Revenue Growth, indicating strong performance in this area. In terms of Gross Profit, Synchrony Financial is at the top compared to its peers. However, for Return on Equity, it is at the bottom among the group.</p>
<h3>About Synchrony Finl</h3>
<p>Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).</p>
<h3>Unraveling the Financial Story of Synchrony Finl</h3>
<p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<p><strong>Revenue Growth:</strong> Synchrony Finl displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately <strong>3.88%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>19.81%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Synchrony Finl's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>5.0%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>0.63%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>1.01</strong>, Synchrony Finl adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/SYF/earnings"><strong>To track all earnings releases for Synchrony Finl visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Preview: Synchrony Finl's Earnings

<p>Truist Securities  analyst Jordan Levy   maintains Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) with a Hold and lowers the price target from $22 to $19.</p>


Truist Securities Maintains Hold on Bloom Energy, Lowers Price Target to $19

<p>Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-22. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Equifax to report an <strong>earnings per share</strong> (EPS) of $1.84.</p>
<p>The announcement from Equifax is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company beat EPS by $0.02, which was followed by a 0.32% increase in the share price the next day.</p>
<p>Here's a look at Equifax's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.10</td>
<td>1.83</td>
<td>1.73</td>
<td>1.44</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.12</td>
<td>1.85</td>
<td>1.82</td>
<td>1.50</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>0.0%</td>
<td>-3.0%</td>
<td>2.0%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251271_0.png" alt="eps graph" /></p>
<h3>Tracking Equifax's Stock Performance</h3>
<p>Shares of Equifax were trading at $221.25 as of April 18. Over the last 52-week period, shares are down 3.56%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Opinions on Equifax</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Equifax.</p>
<p>Equifax has received a total of 9 ratings from analysts, with the consensus rating as Outperform. With an average one-year price target of $296.44, the consensus suggests a potential 33.98% upside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Leidos Holdings, Jacobs Solutions and TransUnion, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Leidos Holdings, with an average 1-year price target of $172.83, suggesting a potential 21.88% downside.</li>
<li>Analysts currently favor an Buy trajectory for Jacobs Solutions, with an average 1-year price target of $146.0, suggesting a potential 34.01% downside.</li>
<li>Analysts currently favor an Neutral trajectory for TransUnion, with an average 1-year price target of $108.25, suggesting a potential 51.07% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
<p>The peer analysis summary outlines pivotal metrics for Leidos Holdings, Jacobs Solutions and TransUnion, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Equifax</td>
<td>Outperform</td>
<td>7.00%</td>
<td>$804.40M</td>
<td>3.59%</td>
</tr>
<tr>
<td>Leidos Holdings</td>
<td>Outperform</td>
<td>9.67%</td>
<td>$693M</td>
<td>6.29%</td>
</tr>
<tr>
<td>Jacobs Solutions</td>
<td>Buy</td>
<td>4.37%</td>
<td>$721.27M</td>
<td>-0.31%</td>
</tr>
<tr>
<td>TransUnion</td>
<td>Neutral</td>
<td>8.65%</td>
<td>$625.20M</td>
<td>1.57%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Equifax ranks first in gross profit and return on equity among its peers. It ranks second in revenue growth and consensus rating.</p>
<h3>About Equifax</h3>
<p>Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.</p>
<h3>Understanding the Numbers: Equifax's Finances</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Equifax showcased positive performance, achieving a revenue growth rate of <strong>7.0%</strong> as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> Equifax's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>12.26%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Equifax's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>3.59%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Equifax's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>1.44%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Equifax's debt-to-equity ratio is below the industry average. With a ratio of <b>1.04</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/EFX/earnings"><strong>To track all earnings releases for Equifax visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Look Ahead: Equifax's Earnings Forecast

<p><strong>PulteGroup</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that PulteGroup will report an <strong>earnings per share</strong> (EPS) of $2.44. </p>
<p>The market awaits PulteGroup's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Overview of Past Earnings</h3>
<p>In the previous earnings release, the company beat EPS by $0.23, leading to a 3.99% drop in the share price the following trading session.</p>
<p>Here's a look at PulteGroup's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>3.27</td>
<td>3.11</td>
<td>3.27</td>
<td>2.36</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>3.50</td>
<td>3.35</td>
<td>3.58</td>
<td>2.87</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-4.0%</td>
<td>-0.0%</td>
<td>-2.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251263_0.png" alt="eps graph" /></p>
<h3>Market Performance of PulteGroup's Stock</h3>
<p>Shares of PulteGroup were trading at $94.95 as of April 18. Over the last 52-week period, shares are down 17.84%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/PHM/earnings"><strong>To track all earnings releases for PulteGroup visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights Ahead: PulteGroup's Quarterly Earnings

<p>Deep-pocketed investors have adopted a bullish approach towards Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PANW usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 35 extraordinary options activities for Palo Alto Networks. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 51% leaning bullish and 37% bearish. Among these notable options, 18 are puts, totaling $743,302, and 17 are calls, amounting to $1,132,690.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $85.0 to $200.0 for Palo Alto Networks over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Palo Alto Networks stands at 851.33, with a total volume reaching 5,466.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Palo Alto Networks, situated within the strike price corridor from $85.0 to $200.0, throughout the last 30 days.</p>
<h3>Palo Alto Networks 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251255_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$14.7</td>
<td>$14.45</td>
<td>$14.65</td>
<td>$185.00</td>
<td>$156.9K</td>
<td>1.7K</td>
<td align="right">108</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$6.35</td>
<td>$6.0</td>
<td>$6.0</td>
<td>$200.00</td>
<td>$138.0K</td>
<td>882</td>
<td align="right">440</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$6.3</td>
<td>$5.85</td>
<td>$6.05</td>
<td>$200.00</td>
<td>$127.0K</td>
<td>882</td>
<td align="right">0</td>
</tr>
<tr>
<td>PANW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$17.3</td>
<td>$17.15</td>
<td>$17.15</td>
<td>$170.00</td>
<td>$111.4K</td>
<td>3.1K</td>
<td align="right">150</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$13.1</td>
<td>$12.95</td>
<td>$13.1</td>
<td>$190.00</td>
<td>$104.8K</td>
<td>1.6K</td>
<td align="right">80</td>
</tr>
</tbody>
</table>
</p>
<h3>About Palo Alto Networks</h3>
<p>Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three fourths of the Global 2000.</p>
<p>Following our analysis of the options activities associated with Palo Alto Networks, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of Palo Alto Networks</h3>
<ul>
<li>With a volume of 1,396,617, the price of PANW is down -4.97% at $159.36. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 28 days.</li>
</ul>
<h3>What Analysts Are Saying About Palo Alto Networks</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $195.2.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from HSBC has elevated its stance to Hold, setting a new price target at $156.<br />
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Palo Alto Networks, which currently sits at a price target of $205.<br />
&#x2A; In a cautious move, an analyst from Stephens &amp; Co. downgraded its rating to Equal-Weight, setting a price target of $205.<br />
&#x2A; An analyst from Keybanc has decided to maintain their Overweight rating on Palo Alto Networks, which currently sits at a price target of $205.<br />
&#x2A; Maintaining their stance, an analyst from Truist Securities continues to hold a Buy rating for Palo Alto Networks, targeting a price of $205. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Palo Alto Networks, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

PANW

Palo Alto Networks Unusual Options Activity

<p>Quest Diagnostics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-22. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Quest Diagnostics to report an <strong>earnings per share</strong> (EPS) of $2.16.</p>
<p>The market awaits Quest Diagnostics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Past Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS beat by $0.05, leading to a 6.83% drop in the share price on the subsequent day.</p>
<p>Here's a look at Quest Diagnostics's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.18</td>
<td>2.26</td>
<td>2.34</td>
<td>1.85</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.23</td>
<td>2.30</td>
<td>2.35</td>
<td>2.04</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-7.000000000000001%</td>
<td>1.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251254_0.png" alt="eps graph" /></p>
<h3>Quest Diagnostics Share Price Analysis</h3>
<p>Shares of Quest Diagnostics were trading at $163.8 as of April 18. Over the last 52-week period, shares are up 11567.39%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analysts' Take on Quest Diagnostics</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Quest Diagnostics.</p>
<p>Analysts have given Quest Diagnostics a total of 10 ratings, with the consensus rating being Neutral. The average one-year price target is $182.5, indicating a potential 11.42% upside.</p>
<h3>Peer Ratings Overview</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Labcorp Hldgs, DaVita and Chemed, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Labcorp Hldgs, with an average 1-year price target of $273.0, suggesting a potential 66.67% upside.</li>
<li>Analysts currently favor an Neutral trajectory for DaVita, with an average 1-year price target of $169.0, suggesting a potential 3.17% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Chemed, with an average 1-year price target of $667.0, suggesting a potential 307.2% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
<p>Within the peer analysis summary, vital metrics for Labcorp Hldgs, DaVita and Chemed are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Quest Diagnostics</td>
<td>Neutral</td>
<td>14.55%</td>
<td>$858M</td>
<td>3.24%</td>
</tr>
<tr>
<td>Labcorp Hldgs</td>
<td>Buy</td>
<td>9.76%</td>
<td>$896.30M</td>
<td>1.77%</td>
</tr>
<tr>
<td>DaVita</td>
<td>Neutral</td>
<td>4.73%</td>
<td>$1.07B</td>
<td>102.13%</td>
</tr>
<tr>
<td>Chemed</td>
<td>Outperform</td>
<td>9.23%</td>
<td>$234.12M</td>
<td>7.67%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Quest Diagnostics ranks in the middle for Consensus rating. It is at the bottom for Revenue Growth and Gross Profit, but at the top for Return on Equity among its peers.</p>
<h3>Get to Know Quest Diagnostics Better</h3>
<p>Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.</p>
<h3>Understanding the Numbers: Quest Diagnostics's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.</p>
<p><strong>Revenue Growth:</strong> Quest Diagnostics's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>14.55%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Quest Diagnostics's net margin is impressive, surpassing industry averages. With a net margin of <strong>8.39%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Quest Diagnostics's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>3.24%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Quest Diagnostics's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>1.36%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>1.05</strong>.</p>
<p><a href="https://www.benzinga.com/quote/DGX/earnings"><strong>To track all earnings releases for Quest Diagnostics visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Examining the Future: Quest Diagnostics's Earnings Outlook

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Tesla</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TSLA, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 509 uncommon options trades for Tesla.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 42% bullish and 44%, bearish.</p>
<p>Out of all of the special options we uncovered, 310 are puts, for a total amount of $44,209,488, and 199 are calls, for a total amount of $14,078,575.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $600.0 for Tesla over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Tesla stands at 3429.45, with a total volume reaching 2,742,542.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Tesla, situated within the strike price corridor from $60.0 to $600.0, throughout the last 30 days.</p>
<h3>Tesla 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251250_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$146.8</td>
<td>$145.7</td>
<td>$146.55</td>
<td>$370.00</td>
<td>$1.0M</td>
<td>3.4K</td>
<td>209</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$117.45</td>
<td>$117.2</td>
<td>$117.2</td>
<td>$340.00</td>
<td>$761.6K</td>
<td>9.4K</td>
<td>253</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$117.2</td>
<td>$116.75</td>
<td>$117.15</td>
<td>$340.00</td>
<td>$562.5K</td>
<td>9.4K</td>
<td>178</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/25/25</td>
<td>$10.65</td>
<td>$10.55</td>
<td>$10.63</td>
<td>$220.00</td>
<td>$363.5K</td>
<td>11.3K</td>
<td>27.4K</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$105.9</td>
<td>$105.7</td>
<td>$105.86</td>
<td>$330.00</td>
<td>$264.6K</td>
<td>3.9K</td>
<td>338</td>
</tr>
</tbody>
</table>
</p>
<h3>About Tesla</h3>
<p>Tesla is a vertically integrated battery electric vehicle automaker and developer of autonomous driving software. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to begin selling more affordable vehicles, a sports car, and offer a robotaxi service. Global deliveries in 2024 were a little below 1.8 million vehicles. The company sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network.</p>
<p>In light of the recent options history for Tesla, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of Tesla</h3>
<ul>
<li>Currently trading with a volume of 42,997,591, the TSLA's price is down by -6.88%, now at $224.75. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 1 days.</li>
</ul>
<h3>Professional Analyst Ratings for Tesla</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $339.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Piper Sandler persists with their Overweight rating on Tesla, maintaining a target price of $400.<br />
&#x2A; Maintaining their stance, an analyst from Stifel continues to hold a Buy rating for Tesla, targeting a price of $455.<br />
&#x2A; An analyst from Mizuho has decided to maintain their Outperform rating on Tesla, which currently sits at a price target of $375.<br />
&#x2A; An analyst from UBS has decided to maintain their Sell rating on Tesla, which currently sits at a price target of $190.<br />
&#x2A; An analyst from Goldman Sachs persists with their Neutral rating on Tesla, maintaining a target price of $275. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Tesla options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


TSLA

Check Out What Whales Are Doing With TSLA

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Exxon Mobil</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with XOM, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Exxon Mobil.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 66% bullish and 33%, bearish.</p>
<p>Out of all of the special options we uncovered, 5 are puts, for a total amount of $302,210, and 4 are calls, for a total amount of $456,325.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $95.0 to $120.0 for Exxon Mobil over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Exxon Mobil's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Exxon Mobil's whale activity within a strike price range from $95.0 to $120.0 in the last 30 days. </p>
<h3>Exxon Mobil 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251245_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$5.4</td>
<td>$5.3</td>
<td>$5.4</td>
<td>$105.00</td>
<td>$326.7K</td>
<td>6.5K</td>
<td>624</td>
</tr>
<tr>
<td>XOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/02/25</td>
<td>$0.55</td>
<td>$0.51</td>
<td>$0.54</td>
<td>$95.00</td>
<td>$108.0K</td>
<td>69</td>
<td>2.0K</td>
</tr>
<tr>
<td>XOM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$7.95</td>
<td>$7.9</td>
<td>$7.95</td>
<td>$110.00</td>
<td>$79.5K</td>
<td>11.5K</td>
<td>110</td>
</tr>
<tr>
<td>XOM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$9.3</td>
<td>$7.35</td>
<td>$8.0</td>
<td>$105.00</td>
<td>$52.0K</td>
<td>740</td>
<td>0</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$2.45</td>
<td>$2.39</td>
<td>$2.43</td>
<td>$115.00</td>
<td>$48.6K</td>
<td>5.0K</td>
<td>433</td>
</tr>
</tbody>
</table>
</p>
<h3>About Exxon Mobil</h3>
<p>ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil worldwide. In 2023, it produced 2.4 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At the end of 2023, reserves were 16.9 billion barrels of oil equivalent, 66% of which were liquids. The company is one of the world's largest refiners, with a total global refining capacity of 4.5 million barrels of oil per day, and is one of the world's largest manufacturers of commodity and specialty chemicals.</p>
<h3>Where Is Exxon Mobil Standing Right Now?</h3>
<ul>
<li>With a volume of 3,608,592, the price of XOM is down -2.15% at $104.62. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 11 days.</li>
</ul>
<h3>What Analysts Are Saying About Exxon Mobil</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $129.6.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Buy rating for Exxon Mobil, targeting a price of $131.<br />
&#x2A; An analyst from UBS persists with their Buy rating on Exxon Mobil, maintaining a target price of $135.<br />
&#x2A; Maintaining their stance, an analyst from Scotiabank continues to hold a Sector Outperform rating for Exxon Mobil, targeting a price of $115.<br />
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Neutral rating on Exxon Mobil with a target price of $129.<br />
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on Exxon Mobil with a target price of $138. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Exxon Mobil with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


This Is What Whales Are Betting On Exxon Mobil

<p>Packaging Corp of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>) will release its quarterly earnings report on Tuesday, 2025-04-22. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Packaging Corp of America to report an <strong>earnings per share</strong> (EPS) of $2.22.</p>
<p>Packaging Corp of America bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings History Snapshot</h3>
<p>In the previous earnings release, the company missed EPS by $0.06, leading to a 9.77% drop in the share price the following trading session.</p>
<p>Here's a look at Packaging Corp of America's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.53</td>
<td>2.50</td>
<td>2.14</td>
<td>1.68</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.47</td>
<td>2.65</td>
<td>2.20</td>
<td>1.72</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-10.0%</td>
<td>6.0%</td>
<td>0.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251245_0_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Packaging Corp of America were trading at $187.19 as of April 18. Over the last 52-week period, shares are up 6.16%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Insights on Packaging Corp of America</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Packaging Corp of America.</p>
<p>The consensus rating for Packaging Corp of America is Buy, derived from 4 analyst ratings. An average one-year price target of $240.0 implies a potential 28.21% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Avery Dennison, International Paper and Graphic Packaging Holding, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Avery Dennison, with an average 1-year price target of $208.4, suggesting a potential 11.33% upside.</li>
<li>Analysts currently favor an Outperform trajectory for International Paper, with an average 1-year price target of $59.33, suggesting a potential 68.3% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Graphic Packaging Holding, with an average 1-year price target of $31.0, suggesting a potential 83.44% downside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Avery Dennison, International Paper and Graphic Packaging Holding, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Packaging Corp of America</td>
<td>Buy</td>
<td>10.74%</td>
<td>$469.70M</td>
<td>5.07%</td>
</tr>
<tr>
<td>Avery Dennison</td>
<td>Outperform</td>
<td>3.56%</td>
<td>$609.20M</td>
<td>7.39%</td>
</tr>
<tr>
<td>International Paper</td>
<td>Outperform</td>
<td>-0.46%</td>
<td>$1.33B</td>
<td>-1.75%</td>
</tr>
<tr>
<td>Graphic Packaging Holding</td>
<td>Neutral</td>
<td>-6.85%</td>
<td>$453M</td>
<td>4.58%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Packaging Corp of America ranks at the top for Revenue Growth and Gross Profit among its peers. It is in the middle for Return on Equity.</p>
<h3>Unveiling the Story Behind Packaging Corp of America</h3>
<p>Packaging Corp. of America is the third-largest containerboard and corrugated packaging manufacturer in the United States. It produces over 4.5 million tons of containerboard annually. The company's share of the domestic containerboard market is roughly 10%. PCA differentiates itself from larger competitors by focusing on smaller customers and operating with a high degree of flexibility.</p>
<h3>Key Indicators: Packaging Corp of America's Financial Health</h3>
<p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Packaging Corp of America's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>10.74%</strong> as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Packaging Corp of America's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>10.23%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Packaging Corp of America's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>5.07%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>2.5%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Packaging Corp of America's debt-to-equity ratio is below the industry average at <strong>0.63</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/PKG/earnings"><strong>To track all earnings releases for Packaging Corp of America visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Examining the Future: Packaging Corp of America's Earnings Outlook

<p>RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-22. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect RTX to report an <strong>earnings per share</strong> (EPS) of $1.36.</p>
<p>Anticipation surrounds RTX's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Earnings History Snapshot</h3>
<p>The company's EPS beat by $0.16 in the last quarter, leading to a 2.51% drop in the share price on the following day.</p>
<p>Here's a look at RTX's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.38</td>
<td>1.34</td>
<td>1.29</td>
<td>1.23</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.54</td>
<td>1.45</td>
<td>1.41</td>
<td>1.34</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-3.0%</td>
<td>1.0%</td>
<td>0.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745251238_0.png" alt="eps graph" /></p>
<h3>Performance of RTX Shares</h3>
<p>Shares of RTX were trading at $128.89 as of April 18. Over the last 52-week period, shares are up 24.04%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analysts' Perspectives on RTX</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on RTX.</p>
<p>RTX has received a total of 13 ratings from analysts, with the consensus rating as Outperform. With an average one-year price target of $147.92, the consensus suggests a potential 14.76% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of GE Aerospace, Lockheed Martin and Northrop Grumman, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for GE Aerospace, with an average 1-year price target of $221.7, suggesting a potential 72.01% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Lockheed Martin, with an average 1-year price target of $508.83, suggesting a potential 294.78% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Northrop Grumman, with an average 1-year price target of $572.3, suggesting a potential 344.02% upside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for GE Aerospace, Lockheed Martin and Northrop Grumman, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>RTX</td>
<td>Outperform</td>
<td>8.51%</td>
<td>$4.24B</td>
<td>2.44%</td>
</tr>
<tr>
<td>GE Aerospace</td>
<td>Outperform</td>
<td>14.33%</td>
<td>$4.05B</td>
<td>9.94%</td>
</tr>
<tr>
<td>Lockheed Martin</td>
<td>Neutral</td>
<td>-1.34%</td>
<td>$690M</td>
<td>7.79%</td>
</tr>
<tr>
<td>Northrop Grumman</td>
<td>Outperform</td>
<td>0.45%</td>
<td>$1.93B</td>
<td>8.42%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>RTX ranks at the top for Revenue Growth among its peers. In terms of Gross Profit, RTX is in the middle. For Return on Equity, RTX is at the bottom compared to its peers.</p>
<h3>Delving into RTX's Background</h3>
<p>RTX is an aerospace and defense manufacturer formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace and to the defense market across three segments: Collins Aerospace, a diversified aerospace supplier; Pratt &amp; Whitney, a commercial and military aircraft engine manufacturer; and Raytheon, a defense prime contractor providing a mix of missiles, missile defense systems, sensors, hardware, and communications technology to the military.</p>
<h3>RTX's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<p><strong>Positive Revenue Trend:</strong> Examining RTX's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>8.51%</strong> as of 31 December, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> RTX's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>6.85%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> RTX's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>2.44%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> RTX's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>0.9%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.71</strong>, RTX adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/RTX/earnings"><strong>To track all earnings releases for RTX visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Comments

Global X Cybersecurity ETF

Actualités

Dernières nouvelles pour Global X Cybersecurity ETF (NASDAQ:BUG)

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL